According to our (Global Info Research) latest study, the global Gastro-retentive Drug Delivery System market size was valued at US$ 11948 million in 2025 and is forecast to a readjusted size of US$ 18049 million by 2032 with a CAGR of 6.0% during review period.
Gastro-retentive Drug Delivery Systems (GRDDS) are advanced oral pharmaceutical platforms designed to prolong the residence time of a drug formulation in the stomach, enabling sustained, controlled release and site-specific delivery to the upper gastrointestinal tract. Unlike conventional oral dosage forms that empty rapidly from the stomach (typically within 1-2 hours), GRDDS can extend gastric retention for up to 24 hours, significantly improving the bioavailability of drugs with narrow absorption windows, pH-dependent solubility, or instability in the lower GI tract. Key technologies include floating systems (low-density formulations that buoy in gastric fluid), mucoadhesive systems (polymers that adhere to gastric mucosa), swelling/expandable systems (large-format tablets that resist gastric emptying), high-density systems (sinking formulations), and magnetic systems. GRDDS are particularly valuable for treating H. pylori infections, peptic ulcers, and for delivering drugs like ribavirin, metformin, and certain antibiotics. From a value chain perspective, upstream includes functional polymer suppliers (HPMC, carbomers, chitosan), gas-generating agent manufacturers, and excipient providers; midstream involves formulation development, technology platform licensing, scale-up, and manufacturing; downstream demand spans pharmaceutical companies, generic drug developers, and CRO/CDMO service providers.
This report is a detailed and comprehensive analysis for global Gastro-retentive Drug Delivery System market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Gastro-retentive Drug Delivery System market size and forecasts, in consumption value ($ Million), 2021-2032
Global Gastro-retentive Drug Delivery System market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Gastro-retentive Drug Delivery System market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Gastro-retentive Drug Delivery System market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gastro-retentive Drug Delivery System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gastro-retentive Drug Delivery System market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Triastek, Inc., Bostal Drug Delivery Co., Ltd., Vivtex Corporation, Clexio Biosciences Ltd., Medimetrics Personalized Drug Delivery, Inc., Lonza Group AG, Catalent, Inc., Evonik Industries AG, Colorcon, Inc., Quotient Sciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Gastro-retentive Drug Delivery System market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Sustained Release
Controlled Release (Zero-Order)
Delayed / Pulsatile Release
Market segment by Buoyancy Generation Method
Effervescent (Gas-Generating) System
Non-Effervescent (Low-Density) System
Market segment by Gastric Retention Duration
Short Retention (< 4 hours)
Medium Retention (4-12 hours)
Long Retention (> 12 hours)
Market segment by Application
Anti-infective (H. pylori Eradication)
Gastroenterology (Peptic Ulcer, GERD)
Metabolic Disorders (Diabetes)
Cardiovascular (Hypertension)
Antiviral Therapy
Market segment by players, this report covers
Triastek, Inc.
Bostal Drug Delivery Co., Ltd.
Vivtex Corporation
Clexio Biosciences Ltd.
Medimetrics Personalized Drug Delivery, Inc.
Lonza Group AG
Catalent, Inc.
Evonik Industries AG
Colorcon, Inc.
Quotient Sciences
AbbVie Inc.
AstraZeneca plc
GlaxoSmithKline plc (GSK)
Novartis AG
Pfizer Inc.
Sanofi S.A.
Sun Pharmaceutical Industries Ltd.
Lupin Limited
Dr. Reddy's Laboratories Ltd.
Cipla Ltd.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gastro-retentive Drug Delivery System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gastro-retentive Drug Delivery System, with revenue, gross margin, and global market share of Gastro-retentive Drug Delivery System from 2021 to 2026.
Chapter 3, the Gastro-retentive Drug Delivery System competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Gastro-retentive Drug Delivery System market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gastro-retentive Drug Delivery System.
Chapter 13, to describe Gastro-retentive Drug Delivery System research findings and conclusion.
Summary:
Get latest Market Research Reports on Gastro-retentive Drug Delivery System. Industry analysis & Market Report on Gastro-retentive Drug Delivery System is a syndicated market report, published as Global Gastro-retentive Drug Delivery System Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Gastro-retentive Drug Delivery System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.